Your session is about to expire
← Back to Search
Action Observation + Mental Imagery for Muscle Wasting (STILL Trial)
N/A
Waitlist Available
Led By Matt S Stock, PhD
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
STILL Trial Summary
This study is evaluating whether a week of knee-joint immobilization leads to muscle atrophy, weakness, and loss of neuromuscular function.
Eligible Conditions
- Muscle Wasting
- Muscle Weakness
- Muscle Atrophy
- Knee Injuries
STILL Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Corticospinal responses
Motor unit behavior
Muscular size
+3 moreSecondary outcome measures
Compliance
Physical activity (Step count)
STILL Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ImmobilizationExperimental Treatment2 Interventions
Participants in the immobilization groups will undergo one week of unilateral knee joint immobilization of the left leg.
Group II: ControlActive Control1 Intervention
The control group will not undergo any intervention.
Find a Location
Who is running the clinical trial?
University of Central FloridaLead Sponsor
79 Previous Clinical Trials
1,098,326 Total Patients Enrolled
Matt S Stock, PhDPrincipal InvestigatorUniversity of Central Florida
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger